CRIT REV THER DRUG 润色咨询

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

出版年份:1984 年文章数:495 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:0.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=73c2685, cover=https://img.medsci.cn/images/journal/cover/2021/CTO_202109271314480320.jpg, fullname=CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, abbr=CRIT REV THER DRUG, pyear=1984, frequence=Bimonthly, articleNumbers=495, citedSelf2015=0.0, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2019年中国人文章占该期刊总数量∞% (2018年为暂无数据), issn=0743-4863, greenSci=https://www.greensci.net/search?kw=0743-4863, scijournal=https://www.scijournal.org/impact-factor-of-CRIT-REV-THER-DRUG.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.227, medsciHotlight=0.744, medsciHotlight5year=1.77487, citescore=4.9, hIndex=72, impactFactor=2.7, orgnization=Begell House Inc., orgnizationUrl=http://www.begellhouse.com, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 2区, smallclassCas=医学 3 区, website=http://dl.begellhouse.com/journals/3667c4ae6e8fd136.html, websiteHits=2847, guideForAuthor=null, guideForAuthorHits=3, submitWebsite=https://submission.begellhouse.com/usr/login.html?prod_code=journals, submitWebsiteHits=945, content=Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, rheumatoid arthritis, HIV infection, and drug addiction. Scientific efforts in the above are of a multidisciplinary nature involving the physical, biological, medical, pharmaceutical, and engineering fields, and biomedical materials. With the vast increase in the numbers of papers and the tendency to fragmentize science, it becomes increasingly difficult to keep abreast of the literature, and even more difficult to sort out and to evaluate the importance and sometimes the reliability of the data, especially in cases where proprietary considerations are involved. Abstracts and non-critical articles often do not provide a sufficiently reliable basis for the proper assessment of a given field without the additional perusal of the original literature. The aim of Critical Reviews in Therapeutic Drug Carrier Systems is to bridge this gap by publishing authoritative, objective, and comprehensive multidisciplinary critical review papers with emphasis on clinical applications. Both invited and contributed articles are considered for publication. The Journal will be of benefit to manufacturers, health-care providers, researchers, and patients, and will have wide appeal to clinicians, scientists, and engineers working in the field of drug carriers., totalCites=1339, brief=CRIT REV THER DRUG杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的中等级别杂志, articleType=本刊可能只接收综述类文章或很多文章不被WOS收录, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=CRIT REV THER DRUG杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=73c2685'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=6.09), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.43), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.07), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.6), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.9)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.011), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=1.0), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.86), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=0.969), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.227)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science , rank=36/164), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=84/300)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0743-4863[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS[ta], article_number=17, article_number_cn=1, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CRIT REV THER DRUG/CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
ISSN
0743-4863
影响指数话题
预警等级
MedSci期刊指数
1.227 (MedSci实时期刊指数) | 1.77487 (5年期刊指数)
CiteScore值
4.9
h-index
72
h5-median
暂无数据
出版社/管理机构
杂志由 Begell House Inc. 出版或管理
出版国家/地区
United States 美国
出版周期
Bimonthly
出版年份
1984
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings
JCR分区
暂无数据
中科院分区
大类:医学 2区
小类:医学 3 区